dp 301
Pill imprint dp 301 has been identified as Methylprednisolone 4 mg.
Methylprednisolone is used in the treatment of asthma; inflammatory conditions; osteoarthritis; asthma, maintenance; gout, acute (and more), and belongs to the drug class glucocorticoids. Risk cannot be ruled out during pregnancy.
Methylprednisolone 4 mg is not subject to the Controlled Substances Act.
See also related documents.
Methylprednisolone Images
- Imprint:
-
dp 301
- Strength:
- 4 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
corn starch
lactose anhydrous
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
stearic acid
- Drug Class:
- Glucocorticoids
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0301
Advertisement
More Methylprednisolone resources
- Methylprednisolone
- Methylprednisolone (Wolters Kluwer)
- Methylprednisolone Solution (Wolters Kluwer)
- Methylprednisolone Suspension (Wolters Kluwer)
- methylprednisolone (Cerner Multum)
- Methylprednisolone (AHFS DI)
- Methylprednisolone Acetate (AHFS DI)
- Methylprednisolone Sodium Succinate (AHFS DI)
- Methylprednisolone Injection (FDA)
- Methylprednisolone Sodium Succinate Injection (FDA)
- Methylprednisolone Tablets (FDA)
- Methylprednisolone (Wolters Kluwer)
Search Again
